Serum insulin‐like, growth factor binding protein‐related protein 1 (IGFBP‐rP1) and endometrial cancer risk in Chinese women
Authors:
Open Access
- 28 April 2012
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 132 (2) , 411-416
Abstract
Hyperinsulinemia and the metabolic syndrome confer increased risks of endometrial carcinoma. The roles of insulin, and, insulin‐like growth factor‐binding proteins (IGFBPs) in the etiology of endometrial carcinoma, remain unclear. We recruited 206 patients with endometrial carcinoma and 350 healthy women to a case–control study of fasting insulin and IGFBP‐related protein 1 (IGFBP‐rP1) in a Chinese tertiary centre. Patients with endometrial carcinoma had higher insulin concentrations (14.8 ± 16.7 vs. 8.1 ± 9.4 μU/mL; p < 0.001) and lower IGFBP‐rP1 levels (17.5 ± 17.2 vs. 22.4 ± 22.8 μg/L; p = 0.018) than controls. High insulin and IGFBP‐rP1 levels were both positively and negatively associated with endometrial cancer (odds ratio for the highest tertile versus the lowest tertile: insulin: 4.11; 95% CI = 2.61–6.47; IGFBP‐rP1: 0.38; 95% CI = 0.24–0.60). Logistic regression analysis confirmed the associations between endometrial carcinoma and fasting insulin or IGFBP‐rP1 after adjustments for age, BMI, serum glucose, cholesterol, triglycerides and high‐density lipoprotein cholesterol (odds ratio for the highest tertile versus the lowest tertile: insulin: 2.13; 95% CI = 1.30–3.49; IGFBP‐rP1: 0.57; 95% CI = 0.34–0.94). Hyperinsulinemia and high IGFBP‐rP1 levels confer altered risks for endometrial carcinoma.Keywords
This publication has 31 references indexed in Scilit:
- The association between metabolic abnormality and endometrial cancer: A large case-control study in ChinaGynecologic Oncology, 2010
- Metabolic Syndrome and Endometrial CarcinomaAmerican Journal of Epidemiology, 2010
- Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal WomenJNCI: Journal of the National Cancer Institute, 2008
- A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial CancerCancer Epidemiology, Biomarkers & Prevention, 2008
- Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7Cell, 2008
- Diabetes and Endometrial Cancer: An Evaluation of the Modifying Effects of Other Known Risk FactorsAmerican Journal of Epidemiology, 2007
- Effect of Insulin-Like Growth Factor-Binding Protein 7 on Steroidogenesis in Granulosa Cells Derived from Equine Chorionic Gonadotropin-Primed Immature Rat OvariesBiology of Reproduction, 2007
- Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; Results from the European prospective investigation into cancer and nutritionInternational Journal of Cancer, 2007
- Prediagnostic levels of C‐peptide, IGF‐I, IGFBP ‐1, ‐2 and ‐3 and risk of endometrial cancerInternational Journal of Cancer, 2003
- Case--Control Study of Endogenous Steroid Hormones and Endometrial CancerJNCI: Journal of the National Cancer Institute, 1996